1,634 material Form 8-K filings that 1,408 companies we cover made with the SEC in November 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). 591 of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
News Corporation filed daily buyback notices with the Australian Securities Exchange covering repurchases made on November 4, 2026, under its program to buy up to $1 billion of Class A and Class B common stock. The company says it has spent approximately $570,425,202 under the program to date, based on total consideration paid. The filing is a routine disclosure required by ASX rules and does not change the size or terms of the program.
Class A common stock: 54,641 shares bought on November 4, 2026, for $1,653,677.08
Class B common stock: 23,784 shares bought on November 4, 2026, for $784,940.97
Cumulative spending under the $1 billion 2025 Repurchase Program to date: approximately $570,425,202
Filing is a daily buy-back notification to the ASX, dated November 5, 2026
UPS appointed Shannon Eisenhardt, Group Chief Financial Officer and Executive Director of Reckitt Benckiser Group plc, to its board effective immediately, expanding the board to eleven members. She also joins the Audit Committee, and the filing does not report any financial results or guidance changes.
Board size set at eleven members; Eisenhardt appointed effective November 4, 2026, including a seat on the Audit Committee
Eisenhardt, 52, previously spent eight years at NIKE, Inc., most recently as CFO of Consumer, Marketplace and Brand (2020 to 2023)
Prorated annual cash retainer of $125,000 and annual equity award of $210,000 for the remainder of the current board service year
Landmark Bancorp furnished an investor presentation dated November 4, 2026, as Exhibit 99.1 to a Form 8-K, for use in investor meetings. The company says the slides provide select quarter- and year-end financial data, but the filing text itself gives no specific figures, and the exhibit's contents were not included in the text provided.
Filing date: November 4, 2026; Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits)
Exhibit 99.1 is an investor presentation dated November 4, 2026, containing reference slides for investor meetings
Slides show select quarter- and year-end financial data; no specific figures appear in the filing text
Information is furnished, not filed, under Section 18 of the Exchange Act
HF Sinclair agreed to buy back 2,100,000 shares of its common stock from REH Advisors Inc. at $110.81 per share, for an aggregate price of approximately $233 million, funded with cash on hand. The repurchase is expected to close on or around November 6, 2026, and is made under the company's $1.5 billion share repurchase program, which leaves about $493 million of authorization remaining.
2,100,000 shares at $110.81 per share, for an aggregate price of approximately $233 million, funded with cash on hand
Stock Purchase Agreement dated November 3, 2026; expected completion on or around November 6, 2026
Made under the $1.5 billion share repurchase program authorized by the Board on August 26, 2026; about $493 million remains, and $1 billion has been repurchased to date including this transaction
Shares will be held as treasury stock; this is the twenty-fourth privately negotiated transaction between the company and REH
Quoin Pharmaceuticals signed a sales agreement with Leerink Partners LLC that lets it sell American Depositary Shares from time to time through an at-the-market offering. Leerink would receive 3.0% of gross sale proceeds, and the filing does not state a dollar amount or number of shares to be sold, so the potential dilution to shareholders is not quantified.
Sales agreement with Leerink Partners LLC dated November 4, 2026; each ADS represents 35 ordinary shares.
Leerink Partners would be paid 3.0% of gross sale proceeds from ADSs sold through it.
Sales are made under Form S-3 (File No. 333-299668), declared effective November 4, 2026; the filing states no aggregate offering size.
Either party may suspend or terminate the agreement at any time upon notice.
Summit Therapeutics filed a prospectus supplement under its automatic shelf registration statement on Form S-3 and an accompanying 8-K to file a legal opinion from Baker & Hostetler LLP on the legality of the common stock issuance. The filing does not state the number of shares, the price, or the amount of proceeds, so the filing alone does not show the size or dilution effect of the offering.
Prospectus supplement filed November 4, 2026 under Form S-3 (Registration No. 333-296642)
Baker & Hostetler LLP legality opinion filed as Exhibit 5.1, with consent as Exhibit 23.1
Filing does not disclose share count, offering price, or proceeds
Olin Corporation and its subsidiary Olin Finance Company, LLC entered into Amendment No. 2 to a receivables purchase agreement with PNC Bank, National Association, on November 4, 2026. The amendment, among other things, extends the scheduled termination date to July 31, 2028, and the filing attaches the full text as Exhibit 10.1; the filing gives no financial amounts for the facility.
Agreement dated November 4, 2026, amends the Receivables Purchase Agreement dated November 20, 2024
Scheduled termination date extended to July 31, 2028
Olin Corporation acts as servicer and performance guarantor; PNC Bank, National Association is administrative agent
Star Equity Holdings' subsidiary Hudson Talent Solutions completed its asset purchase of Cornerstone RPO, LLC on November 2, 2026, paying $500,000 at closing with additional deferred and contingent payments possible. The filing discloses the deal terms but no financial results for Cornerstone, so shareholders cannot assess its size relative to Star's results from the filing alone.
Hudson Talent Solutions paid $500,000 at closing on November 2, 2026, of which $100,000 is held in escrow for the Sellers' indemnification obligations.
$250,000 of fixed deferred consideration is payable under an unsecured, non-interest-bearing note over 36 monthly installments, absent default.
Up to $1.5 million in earnouts is payable in three $500,000 payments if cumulative legacy-client revenue reaches $6,000,000, $12,000,000 and $20,000,000 within 36 months; each payment is 75% cash and 25% in 10% Series A Cumulative Perpetual
An additional $250,000 may be paid if certain client contracts are legally transferred or certain business is established with Hudson Talent Solutions.
On November 4, 2026, WEC Energy Group entered into an equity distribution agreement allowing it to sell up to $4 billion of common stock through a group of sales agents and forward purchasers. The company expects to receive proceeds only when shares are sold and settled under forward sale agreements, and no proceeds are received from borrowed shares sold initially, so the program could dilute existing shareholders as shares are issued.
Maximum aggregate sales price under the Equity Distribution Agreement is $4 billion of common stock, $0.01 par value.
Sales agents include Barclays, BofA Securities, Citigroup, Goldman Sachs, J.P. Morgan, Morgan Stanley and Wells Fargo, among others.
Company will not initially receive proceeds from borrowed shares sold by forward sellers; proceeds come at later physical settlement.
On November 4, 2026, STERIS and its subsidiaries entered a new $1.6 billion revolving credit facility that replaces the existing credit agreement dated October 7, 2024, and a separate delayed draw term loan of up to $500 million. The term loan can be drawn only if STERIS completes its acquisition of Xodus Medical, Inc. For shareholders, the filing adds committed borrowing capacity tied to that acquisition, and the filing does not state the acquisition price or the amount that will be borrowed.
Revolving credit facility of $1,600 million matures on November 4, 2031, with an incremental increase of up to $800 million available.
Delayed draw term loan of up to $500 million can be used only after the Xodus Medical Acquisition is consummated and terminates if that deal is validly terminated or the outside date occurs.
Term loan matures five years after the acquisition closing date; no principal is due in year one, then 1.25% quarterly in years two and three and 1.875% quarterly in years four and five.
No borrowings were incurred to refinance the existing credit agreement at closing, and all term loan lenders are also lenders under the revolver.
Pinnacle Financial Partners furnished investor presentation materials for a fireside chat at the BancAnalysts Association of Boston Conference on November 5, 2026. The filing is routine and contains no new financial results, guidance changes, or transaction terms, though the deck discusses integration of the recently completed Synovus business combination.
Fireside chat scheduled for November 5, 2026 at 2:10 p.m. ET
Presentation materials furnished as Exhibit 99.1 and posted at investors.pnfp.com
Deck states the March 2027 core and brand conversion is on track following the Synovus combination
Finward Bancorp, the holding company for Peoples Bank, declared a quarterly dividend of $0.12 per share on November 4, 2026. The filing gives no earnings, guidance, or other financial results, so the announcement shows a dividend declaration only.
Dividend amount: $0.12 per common share
Payable December 2, 2026 to shareholders of record at the close of business on November 18, 2026
Declared by the Board of Directors on November 4, 2026; the filing includes no earnings or guidance figures
Regions executives will present to institutional investors at meetings in November and December 2026, and the company furnished the presentation materials as Exhibit 99.1 to a Form 8-K. The deck restates 3Q26 results and offers near-term expectations, including a 4Q26 net interest income forecast of a 1% to 2% increase from 3Q26.
3Q26 net income available to common shareholders was $611 million, with diluted earnings per share of $0.71 as reported.
Management expects 4Q26 net interest income to rise 1% to 2% versus 3Q26, with net interest margin of about 3.70%.
The presentation is furnished under Regulation FD and is also posted on regions.com.
On November 4, 2026, Kimberly-Clark settled exchange offers under which holders of Kenvue notes, assumed after its merger with Kenvue, exchanged them for new Kimberly-Clark notes with the same rates and maturities. The amendments removed substantially all restrictive covenants from the Kenvue notes still outstanding, so the financing terms for shareholders change mainly through the new Kimberly-Clark debt and the reduced protections for remaining Kenvue noteholders.
Settlement date was November 4, 2026; exchange offers expired November 2, 2026
Kimberly-Clark issued seven series of notes, with accepted principal ranging from $702,706,000 (4.850% notes due 2032) to $1,478,073,000 (5.050% notes due 2053)
Early participants received $970 principal of new notes, a $30 premium and $1.00 cash per $1,000 Kenvue notes tendered
Kimberly-Clark notes are general, unsecured senior obligations ranking equally with its existing unsecured senior debt
Applied Optoelectronics entered a new Credit Agreement on October 30, 2026, with East West Bank as administrative agent, providing $30 million in revolving commitments and $170 million in initial term loan commitments. The company terminated its prior $35 million unused-revolver facility with BOK Financial on October 29, 2026, paying a $350,000 termination fee; the new facility matures October 30, 2030 and is secured by substantially all company assets.
New Credit Agreement dated October 30, 2026: $30 million revolving commitments and $170 million initial term loan commitments
Incremental term loan commitments of up to $50 million available subject to certain conditions
Prior Loan and Security Agreement dated July 31, 2025 terminated October 29, 2026; $350,000 termination fee paid
New facility matures October 30, 2030 and is secured by substantially all company assets
Astera Labs disclosed that director Michael Hurlston resigned from its Board of Directors and all committees, effective November 3, 2026, after notifying the company on November 2, 2026. The filing states there were no disagreements with the company and that the resignation was not related to its operations, policies or practices.
Michael Hurlston resigned as a board member and from any committees, effective November 3, 2026
Notice of resignation was given to the company on November 2, 2026
Filing states no disagreements with the company and no link to operations, policies or practices
At its November 4, 2026 annual meeting, Rallybio stockholders approved the issuance of Rallybio common stock to Avenzo securityholders under the May 31, 2026 merger agreement, a share issuance the filing says will result in a change of control. Stockholders also approved a reverse stock split at a ratio of 1-for-2 to 1-for-9, a name change to Avenzo Therapeutics, Inc., and an increase in authorized shares. The filing says the board will be reconstituted upon completion of the merger.
Share issuance to Avenzo securityholders approved with 4,506,703 votes for, 15,979 against, 14 abstaining and 267,624 broker non-votes.
Reverse split ratio range of 1-for-2 to 1-for-9 approved; final ratio to be mutually determined by Rallybio and Avenzo.
Authorized common shares to increase from 200,000,000 to 500,000,000; name change to Avenzo Therapeutics, Inc. approved.
Avenzo 2026 Equity Incentive Plan and 2026 Employee Stock Purchase Plan approved, both effective only upon completion of the merger.
VSE Corporation's Board of Directors declared a regular quarterly cash dividend of $0.10 per share on November 3, 2026. The dividend is payable to stockholders of record as of January 15, 2027, and the company announced it in a press release attached to the filing as Exhibit 99.1.
Quarterly cash dividend of $0.10 per share of VSE common stock
Record date: close of business on January 15, 2027
Independent Bank Corporation (NASDAQ: IBCP) said members of management will present at the HOVDE Group Financial Services Conference on November 5, 2026. The slide presentation is furnished as Exhibit 99.1, and the filing states it is not deemed filed under Section 18 of the Securities Exchange Act of 1934. The filing reports no new financial results, and the slides mainly repeat previously reported third-quarter 2026 figures.
Management presentation at the HOVDE Group Financial Services Conference on November 5, 2026
Slide presentation furnished as Exhibit 99.1 to the Form 8-K
Slides cite third-quarter 2026 net income of $17.9 million, or $0.80 per diluted share, and total assets of $6.3 billion
CBL & Associates Properties' Board of Directors authorized a new common stock repurchase program of up to $25.0 million, which replaces the program authorized on November 5, 2025. The company may buy shares on the open market, in privately negotiated transactions or otherwise through December 31, 2027, depending on market prices and other conditions. The filing does not commit the company to any particular amount of repurchases.
Program authorizes up to $25.0 million of common stock repurchases.
Replaces the existing program authorized on November 5, 2025.
Purchases may be made through December 31, 2027, and the program may be suspended or discontinued at any time.
CEO Stephen D. Lebovitz cited a cash balance of over $366.0 million and no major debt maturities until 2028.
Atmos Energy said Chairman Kim R. Cocklin will retire from the board and as Chairman at the 2027 Annual Meeting after reaching mandatory retirement age. The board approved combining the Chairman and Chief Executive Officer roles, so President and CEO J. Kevin Akers will become Chairman, subject to re-election as a director. Shareholders will see one executive holding both top roles, with an independent Lead Director continuing under the company's governance guidelines.
Kim R. Cocklin, Chairman since December 2020 and with the company since 2006, will not stand for re-election at the 2027 Annual Meeting.
J. Kevin Akers, President and CEO, will become Chairman of the Board at the 2027 Annual Meeting, subject to shareholder re-election.
Nancy K. Quinn, the current Lead Director, will continue in that role from the 2027 Annual Meeting, subject to her re-election.
The board approved the change on November 3, 2026; the filing says Cocklin's decision was not the result of any disagreement with the company.
Oracle issued 86,206,897 shares of common stock under an underwriting agreement dated November 2, 2026, with the offering closing on November 4, 2026. It also sold $10 billion of notes in five tranches maturing from 2029 to 2046, with net proceeds for general corporate purposes, which may include capital expenditures, debt repayment, acquisitions, dividends or buybacks. Shareholders face dilution from the new shares, and the filing does not state the net proceeds or how they will be allocated.
Common stock: 86,206,897 shares sold under an underwriting agreement with BofA Securities, Inc. as representative, closed November 4, 2026
Notes issued November 4, 2026: 7.000% due 2029 ($2.0 billion), 7.450% due 2031 ($1.75 billion), 7.850% due 2033 ($2.25 billion), 8.000% due 2037 ($2.5 billion), 8.650% due 2046 ($1.5 billion)
Net proceeds from both offerings will fund general corporate purposes, which may include capital expenditures, debt repayment, acquisitions and shareholder payouts
Noble Corporation plc said on October 29, 2026 that it promoted Joey M. Kawaja, previously Senior Vice President of Operations since October 2022, to Executive Vice President and Chief Operating Officer, effective November 1, 2026. The filing reports an internal promotion of an operations executive and contains no financial results, guidance, or compensation terms.
Joey M. Kawaja promoted to Executive Vice President and Chief Operating Officer
Promotion announced October 29, 2026; effective November 1, 2026
Kawaja previously served as Senior Vice President of Operations since October 2022
Middleby and its subsidiary Middleby Marshall entered a new five-year Ninth Amended and Restated Credit Agreement with Bank of America as administrative agent, providing a $2.0 billion multicurrency revolver and a $1.0 billion USD term loan A. The facilities refinance the prior credit agreement and may be used for working capital, acquisitions, share repurchases and other general corporate purposes. The filing describes a larger committed borrowing base and new covenants, which matter to shareholders because the debt is secured by substantially all assets of the company and key subsidiaries.
Total new facilities of $3.0 billion: $2.0 billion revolver and $1.0 billion term loan A, maturing November 4, 2031
Interest margins range from 1.250% to 1.750% over benchmark rates, tied to Total Net Leverage Ratio; base rate margins 0.250% to 0.750%
Financial covenants include maximum Secured Net Leverage Ratio of 3.75 to 1.00 and minimum Consolidated Interest Coverage Ratio of 3.00 to 1.00
Facilities may be increased by the greater of $618 million and 100% of consolidated EBITDA, subject to leverage tests
HP's Board appointed Emma Walmsley, former CEO of GSK, as Chief Executive Officer effective January 4, 2027, succeeding interim CEO Bruce Broussard, who will become Board Chair on the same date and succeed Chip Bergh. The filing discloses her offer letter terms, including a $1,450,000 base salary, a $30,000,000 one-time inducement equity award and a $2,500,000 sign-on bonus, and the Board increases its authorized directorships from 12 to 13 to seat her. The filing contains no financial results, so the change is a leadership transition whose effect on performance is not stated.
Emma Walmsley, 57, served as GSK CEO from April 2017 until December 2025 and joins HP as CEO on January 4, 2027.
Bruce Broussard, interim CEO since February 2026, becomes Board Chair on January 4, 2027, succeeding Chip Bergh.
Offer letter sets a $1,450,000 annual base salary and a 200% target bonus, with a $30,000,000 one-time inducement equity award.
Walmsley receives a $2,500,000 sign-on bonus, subject to prorated repayment if she leaves voluntarily or is terminated for misconduct within 12 months.
Citius Pharmaceuticals said its majority-owned subsidiary, Citius Oncology, issued a press release on November 4, 2026, presenting health-related quality of life results from pivotal Study 302 of LYMPHIR in relapsed or refractory cutaneous T-cell lymphoma. The data were presented at the EORTC-CLTG 2026 Annual Meeting in Berlin, held October 8–10, 2026. The filing states the quality of life analyses were exploratory and descriptive, with no formal statistical comparisons, and it contains no financial results or guidance.
Responders (n=25) in the primary analysis set showed mean Skindex-29 Total Score changes from -5.38 to -13.69 points, where lower scores indicate better quality of life.
Responders' FACT-G Total Score change at end of treatment was +3.21, compared with -2.28 for non-responders.
Among 41 patients with a baseline itch score of 20 mm or greater, 13 (32%; 95% CI, 18.1–48.1) achieved a clinically meaningful itch improvement.
Citius Oncology is partnering with the Cutaneous Lymphoma Foundation on a Quality of Life Workshop scheduled for November 2026.
Universal Corporation increased its board to 10 members and appointed Gregory R. Friedman as a new independent director, effective November 4, 2026. The filing says he is expected to join the Audit Committee, the Nominating, Governance and Risk Committee, and the Finance and Pension Investment Committee. The change adds a director with prior chief financial officer experience at Corteva and DuPont Pioneer.
Board size increased to 10 members; Gregory R. Friedman appointed effective November 4, 2026
Board determined Friedman is independent under NYSE listing standards
Expected committee roles: Audit; Nominating, Governance and Risk; Finance and Pension Investment
Friedman was most recently CFO of Mura Technology and previously EVP and CFO of Corteva, Inc.
FS Credit Opportunities Corp. (NYSE: FSCO) said it will release its third quarter 2026 financial results after the market close on Monday, November 23, 2026, and will post an earnings presentation on its website the same day. A recorded earnings call and transcript will follow on Tuesday, November 24, 2026. The filing is a scheduling notice and does not disclose any financial results.
Third quarter 2026 results, for the period ended September 30, 2026, will be released after market close on November 23, 2026.
An earnings presentation with financial information will be posted on the investor relations section of the FSCO website on November 23, 2026.
A recorded earnings call and transcript will be made available on November 24, 2026, after market close.
Westinghouse Air Brake Technologies completed a $500 million offering of 5.900% senior notes maturing February 25, 2037. The company plans to use the proceeds, along with revolver, short-term and commercial paper funding, to repay its 3.45% senior notes due November 15, 2026. The filing adds long-term debt but describes it as refinancing existing maturing debt, and the filing does not report earnings or guidance.
Notes: $500 million aggregate principal, 5.900% coupon, maturing February 25, 2037
Interest payable semi-annually on February 25 and August 25, starting February 25, 2027
Proceeds intended to repay 3.45% senior notes due 2026 at maturity on November 15, 2026
Change of control triggers an offer to repurchase at 101% of principal; notes are unsecured and guaranteed by subsidiaries
Accuray's board approved a 1-for-40 reverse stock split of its common stock, effective at 12:02 a.m. Eastern Time on November 9, 2026, with shares continuing to trade on Nasdaq under ARAY. The press release says the split is intended to raise the per-share trading price and help the company regain compliance with Nasdaq's minimum bid price requirement; shareholders keep the same percentage ownership, except for cash paid in lieu of fractional shares.
Every 40 shares of common stock will combine into one share; outstanding shares fall from approximately 120.2 million to approximately 3.0 million.
Authorized common stock falls from 400,000,000 to 10,000,000 shares; new CUSIP is 004397 303.
Trading on a split-adjusted basis begins when Nasdaq opens on November 9, 2026; Computershare is the exchange agent.
Carrier Global completed an underwritten offering of $750 million of 5.000% notes due 2029 and $750 million of 5.350% notes due 2033, totaling $1.5 billion. The company plans to use the net proceeds mainly to refinance existing debt, including repaying its 2.493% notes due February 15, 2027, with any remainder for general corporate purposes.
Offering totals $1.5 billion: $750 million of 5.000% notes due November 4, 2029 and $750 million of 5.350% notes due November 4, 2033
Proceeds intended to repay at maturity the 2.493% notes due February 15, 2027, and for general corporate and working capital purposes
Notes are unsecured senior obligations; interest paid semi-annually on May 4 and November 4, starting May 4, 2027
Holders can require repurchase at 101% of principal upon a change of control triggering event
Sensient Technologies expanded its board from nine to ten members and elected Ernest Chan and Philip Yu as directors, effective December 2, 2026. One seat fills the vacancy left by the September 2026 death of Essie Whitelaw, and the other is a newly created seat. Board additions are routine governance steps and the filing does not report any financial effect.
Board increased from nine to ten members; Ernest Chan and Philip Yu elected effective December 2, 2026
One seat fills the vacancy created when Essie Whitelaw passed away in September 2026
Both will serve on the Scientific Advisory Committee and receive standard non-employee director pay, including a pro rata 2026 cash retainer
Freeport-McMoRan's Board of Directors approved a $4.5 billion expansion and modernization program for its wholly owned Bagdad copper and molybdenum operation in northwest Arizona. The filing says the project would lift annual long-term copper output to over 400 million pounds, about 225 million pounds more, with initial production targeted for mid-2030. For shareholders, this is a large, multi-year capital commitment, with planned spending to be incorporated into the company's updated capital expenditure outlook and classified as discretionary.
Future incremental capital costs for a new concentrator, mining equipment and expanded infrastructure are expected to approximate $4.5 billion.
Annual long-term production would exceed 400 million pounds of copper (about 225 million pounds incremental) and over 20 million pounds of molybdenum (about 12 million pounds incremental).
Construction is expected to take about 3.5 years, with about 20% of project costs funded in 2027, 30-35% in 2028 and the balance in 2029-2030.
Project break-even economics are supported at a copper price of approximately $4.00 per pound, and the company expects a roughly 20% reduction in long-term unit net cash costs.
InvenTrust Properties Corp. expanded its board from eight to nine members and appointed Robert A. Garechana as an independent director, effective immediately, with a seat on the Audit Committee. Mr. Garechana is executive vice president and chief financial officer of Sun Communities, Inc., and previously served as CFO and Chief Investment Officer at Equity Residential.
Board size increased from eight to nine members; Garechana serves until the 2027 annual meeting.
Garechana joins the Audit Committee and receives compensation under the non-employee director program.
Filing states no arrangement with any other person led to his selection and no related-party interest under Item 404(a).
Monro amended its Rights Agreement to extend the final expiration date from 5:00 p.m. Eastern Time on November 6, 2026 to 5:00 p.m. Eastern Time on November 1, 2027, unless the rights are earlier redeemed, exchanged or terminated. The Board said the extension supports the company's ongoing review of strategic alternatives and is intended to preserve its ability to conduct that review and protect the company and its shareholders.
Final expiration date moves from November 6, 2026 to November 1, 2027.
Amendment dated November 4, 2026, with Equiniti Trust Company, LLC as rights agent.
Original Rights Agreement is dated November 10, 2025.
Board cites the ongoing review of strategic alternatives as the reason for the extension.
Fastly said its President, Go to Market, Scott Lovett, plans to retire during 2027, and the company has begun searching for a Chief Revenue Officer. Under a separation agreement dated October 30, 2026, he will stay in his role through a transition period and then serve as a non-employee Senior Advisor through June 30, 2027, unless extended.
Retirement date to be determined during 2027; Lovett keeps his $450,000 base salary and $450,000 target annual commission until then
Lovett receives no new equity awards during the transition period but continues vesting existing awards through the consulting period
Consulting period runs through June 30, 2027, with a possible extension by written agreement
Fastly is conducting a search for a new Chief Revenue Officer; CEO Kip Compton will lead the search with Lovett
C.H. Robinson Worldwide disclosed amendments dated November 2, 2026, to its existing credit agreement with U.S. Bank National Association as administrative agent and to its note purchase agreement with noteholders. The filing does not state new borrowing amounts, interest rates or maturities, so the size and terms of the changes cannot be determined from this document.
Sixth Omnibus Amendment, dated November 2, 2026, amends a credit agreement originally dated October 29, 2012, with U.S. Bank National Association as administrative agent.
Fourth Amendment to Note Purchase Agreement, dated November 2, 2026, was entered into with noteholders and guarantors.
Certain schedules and exhibits were omitted under Item 601(a)(5) of Regulation S-K and will be provided to the SEC on request.
BWX Technologies said it launched a private offering of $500 million of senior notes due 2034 and, separately, cash tender offers for its two outstanding $400 million series of 4.125% senior notes due 2028 and 2029. The company plans to use the new notes' proceeds, with cash on hand, to buy back the older notes and satisfy and discharge the related indentures, which would refinance existing debt rather than add a stated amount of new debt beyond the $500 million offering.
Private offering of $500 million aggregate principal of senior unsecured notes due 2034, guaranteed by certain wholly-owned subsidiaries
Tender offers cover any and all of the $400 million 4.125% notes due 2028 and $400 million 4.125% notes due 2029
Offers and consent solicitations expire at 5:00 p.m. New York City time on November 10, 2026; settlement expected November 13, 2026
Consents sought would eliminate substantially all restrictive covenants and certain events of default in each indenture
Viasat's board committee adopted the Viasat Value Creation Incentive Program (V-CIP), which grants performance-based restricted stock units that vest only if the stock reaches price hurdles between $150 and $300 through 2030. The committee expects to approve initial awards in December 2026 and plans to allocate a significant portion to Chairman and CEO Mark Dankberg, which may matter to shareholders given potential dilution from the shares involved.
Initial awards of up to 2.8 million PSUs expected, assuming the highest hurdle is met
Price hurdles of $150, $188, $225, $263 and $300, versus a $74.11 close on November 2, 2026
Performance period ends December 31, 2030, with a four-year service-based vesting requirement
Runway Growth Finance Corp. (Nasdaq: RWAY) said its board declared a fourth quarter 2026 regular dividend of $0.33 per share on November 4, 2026. The filing sets the record date for stockholders as November 17, 2026, and the payment date as on or about December 3, 2026, so shareholders on the record date will receive the payout.
Dividend amount: $0.33 per share, declared November 4, 2026
Record date: November 17, 2026
Payment date: on or about December 3, 2026
Stockholders who have not opted out of the dividend reinvestment plan will have cash dividends reinvested in additional shares
Hewlett Packard Enterprise's board approved a cash dividend of $0.953125 per share on its 7.625% Series C Mandatory Convertible Preferred Stock. The dividend is payable December 1, 2026, to holders of record as of November 15, 2026. The filing is a routine declaration on a preferred security and contains no financial results or guidance.
Dividend amount: $0.953125 per share on the 7.625% Series C Mandatory Convertible Preferred Stock
Record date: November 15, 2026; payment date: December 1, 2026
Declaration remains at the Board's discretion and must come from legally available sources
Neogen said it expects regulatory review of its planned sale of its global Genomics business to Zoetis to conclude in early 2027. The deal, first announced March 2, 2026, remains subject to customary closing conditions and regulatory approvals, and Zoetis has offered to divest certain Australian assets to help clear the review. The filing gives no purchase price or financial impact, so shareholders face a longer timeline before the transaction can close.
Neogen agreed on March 2, 2026 to sell its global Genomics business to Zoetis Inc.
The Australian Competition and Consumer Commission and New Zealand Commerce Commission are continuing reviews of the transaction.
Zoetis has offered to divest certain assets in Australia to assist the clearance process.
Neogen expects regulatory review to conclude in early 2027.
McGrath RentCorp issued and sold $75 million of 6.53% unsecured Series H Senior Notes on November 2, 2026, under an amended note purchase agreement. The amendment also raised the company's revolving private shelf facility to $350 million and increased default thresholds from $10 million to $20 million, which gives the company more borrowing capacity and room before cross-default triggers.
Notes: $75 million principal, 6.53% interest, maturing November 2, 2031
Shelf facility capacity increased to $350 million, less notes outstanding and accepted but not yet issued
Cross-default and judgment thresholds raised from $10 million to $20 million
Company may prepay notes at 100% of principal plus a make-whole amount
Powell Industries' Board of Directors declared a quarterly cash dividend of $0.09 per share, announced in a November 3, 2026 press release. Shareholders of record at the close of business on November 18, 2026 will receive the payment on December 16, 2026.
Quarterly cash dividend of $0.09 per share declared
Record date: close of business on November 18, 2026
Textron issued and sold $350 million principal amount of 5.500% Notes due March 15, 2032, under its existing S-3 shelf registration, with the underwriting agreement dated November 2, 2026. The filing is a debt financing that adds $350 million to the company's borrowings, and it does not report earnings, guidance or a change in operations.
Notes: $350 million principal amount, 5.500% coupon, due March 15, 2032
Issued November 4, 2026 under Form S-3 (No. 333-293711) and a prospectus supplement dated November 2, 2026
BofA Securities, Inc. and Citigroup Global Markets Inc. acted as underwriters' managers
On November 4, 2026, Caliber (CaliberCos Inc.) said three more tokenized real estate offerings are live, with up to $85 million of combined offered equity. Investors in these offerings can choose a digital ownership token or a paper certificate, and the filing reports no financial results or guidance. The offerings are limited to accredited investors and are governed by their offering documents.
Three offerings are live: Caliber-Hyatt Studios Steamboat, Caliber-Hyatt Studios Phoenix/TSMC and the Caliber-HS Feeder Fund, with up to $85 million of combined offered equity.
Investors can receive a tokenized digital ownership certificate or keep the existing paper certificate.
With the earlier PURE Pickleball & Padel offering, the four live offerings represent more than $110 million of combined maximum offered equity, against an initial $100 million tokenization target.
Ensysce Biosciences said director Will Chang intends to resign after the next annual meeting, and CEO Dr. Lynn Kirkpatrick will step down as CEO and take the title of Chief Operating Officer right after that meeting. President James Morrisson is set to become CEO at the same time, a change the company had previously reported, which gives shareholders a planned leadership transition.
Annual meeting scheduled for December 14, 2026; Kirkpatrick's title change and Chang's resignation take effect around it, and both would be delayed if the meeting is delayed.
James Morrisson, the company's President, will assume the title of Chief Executive Officer immediately after the annual meeting.
Kirkpatrick agreed to amend her September 14, 2021 employment offer letter so that taking the COO role will not trigger severance obligations.
Kirkpatrick has been CEO since January 2009 and also serves as CEO of EBIR, Inc., in which the company owns 79.2%.
UFP Industries said Scott Worthington, currently president of UFP Packaging, has been named vice president of investor relations, with his transition beginning in November 2026. He succeeds Stanley Elliott, the company's director of investor relations, who has accepted a role outside the company. The change concerns investor communications rather than financial results, operations, or guidance.
Scott Worthington, currently president of UFP Packaging, named vice president of investor relations
Worthington begins transitioning into the role in November 2026
He succeeds Stanley Elliott, director of investor relations, who has accepted a role outside the company
Announced in a press release dated November 4, 2026, filed as Exhibit 99.1
CRH plc said its subsidiary CRH America Finance, Inc. has started cash tender offers for Arcosa, Inc. notes and exchange offers for up to $1.0 billion of new CRH America Finance notes, following CRH's acquisition of Arcosa completed October 23, 2026. Arcosa is also soliciting consents to amend the indentures governing those notes, which would eliminate certain covenants, restrictive provisions, events of default and guarantee provisions. The offers are conditioned on proceeds from a concurrent public offering of senior debt by CRH America Finance, guaranteed by CRH plc, and the filing describes this as a refinancing of acquired debt rather than a change in operating results.
Tender offers cover $400 million of 4.375% notes due 2029 and $600 million of 6.875% notes due 2032
Early tender deadline is November 18, 2026; early settlement expected November 20, 2026; offers expire December 4, 2026
Total tender consideration is $983.75 (2029 notes) and $1,035.00 (2032 notes) per $1,000 principal, including a $50 early tender premium
Exchange offers are capped at up to $1,000,000,000 aggregate principal of new CRH America Finance notes guaranteed by CRH plc
Enova International announced a proposed offering of up to $600 million in senior notes due 2031 and a conditional full redemption of its outstanding 11.25% senior notes due 2028, which total about $400 million. The redemption is conditioned on receiving proceeds from new financing and is set for December 15, 2026, at 102.813% of principal plus accrued interest. The filing does not report earnings or guidance, so the effect on shareholders depends on how the refinancing is completed.
Proposed offering of up to $600 million in senior unsecured notes due 2031, subject to market conditions
Conditional full redemption of about $400 million of 11.25% senior notes due 2028 on December 15, 2026
Redemption price is 102.813% of principal plus accrued and unpaid interest
Company may delay or rescind the redemption if financing conditions are not met by the redemption date
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.